| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |